This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Terry Reed
Director Business Development, Innovation Strategy & External Liaison at Astrazeneca


Terry Reed is a Director of Business Development in the Innovation Strategy & External Liaison function at AstraZeneca and has worked in the pharmaceutical industry for over 13 years. He has specific responsibility for the enhancement of AstraZeneca's Pharmaceutical Technology and Development capabilities, by enabling access to the best external science, technology and innovation. Terry has previous considerable experience in supporting Discovery opportunities with a specific focus on toxicological sciences. He’s been responsible for negotiating and executing over 250 transactions for a broad spectrum of activities spanning in-licensing/out-licensing of technology platforms and intellectual property as well as collaborations and consortiums with industry, biotech and academic partners.

Prior to joining AstraZeneca Terry was Director of Commercial Development at Pharmagene. In all Terry has more than 25 years commercial experience in the life science sector, having also held business development and management positions at Oxford Gene Technology, De Novo Pharmaceuticals, Applied Biosystems, Amersham and Millipore.

Agenda Sessions

  • Panel Discussion: Partnering to Commercialise Therapeutic Platform Technologies for Drug Discovery and Development